PRE-MARKET INDIAN STOCKS NEWS: Cochin Shipyard (COCHIN IS) signed contract worth over INR 20bln with CMA CGM for design and construction of six feeder container vessels

Cochin Shipyard's new contract with CMA CGM to design and build six feeder container vessels is a strong indicator of growth in their shipbuilding segment, valued at over INR 20 billion.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

Japan sells JPY 608bln 20-year JGBs; b/c 3.08x (prev. 3.19), average yield 2.968% (prev. 3.253%)

US is pushing NATO to cut many foreign activities, including ending a key alliance mission in Iraq, according to four NATO diplomats cited by POLITICO

PRE-MARKET INDIAN STOCKS NEWS: Cochin Shipyard (COCHIN IS) signed contract worth over INR 20bln with CMA CGM for design and construction of six feeder container vessels

[MARKET ANALYSIS] Asia-Pac stocks are higher with outperformance in South Korea as tech stocks play catch up on return from the holiday closure

[MARKET ANALYSIS] DXY pauses after strengthening yesterday on better-than-expected data, higher yields, rising oil prices and mixed FOMC views

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Cochin Shipyard (COCHIN IS) - Co. secured contract worth over INR 20bln from CMA CGM to design and build six feeder container vessels. (Moneycontrol)

Dr Reddy’s Laboratories (DRRD IS) - Co. agreed to acquire Progynova and Cyclo-Progynova trademarks and related India assets from Mercury Pharma for USD 32.15mln. (Moneycontrol)

Hindustan Unilever (HUVR IS) - Co. plans INR 20bln investment over two years to expand manufacturing capacity in premium beauty & wellbeing and home care segments. (Moneycontrol)

Tata Consultancy Services (TCS IS) - Tata Group's data centre business signs OpenAI as a customer. (Newswires)

Zydus Lifesciences (CDH IS) - Co. received final US FDA approval for Bosentan tablets for oral suspension. (Moneycontrol)

Context

This substantial order not only boosts Cochin's revenue outlook but also reflects ongoing demand in the logistics sector, potentially influencing investor sentiment towards the company and its peers in the maritime industry. Given the context of India’s expanding maritime capabilities, this deal could also enhance competitive positioning in the region.

Related headlines

The whole workspace, free to try.

Try it free